Altruist Biologics
Suzhou, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (6)
○ EMA GMP
○ MHRA GMP
Quick Facts: Altruist Biologics
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Suzhou, China
- Modalities
- Biologics, mAb, Bispecific/Multispecific Antibodies, Fusion Proteins, Recombinant Proteins, ADC, Cell Therapy, Gene Therapy
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, mAb, Bispecific/Multispecific Antibodies, Fusion Proteins, Recombinant Proteins, ADC, Cell Therapy, Gene Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (8 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Capacity status: Available
StatusAvailable
Broad modality coverage (8 modalities)
Recent Press6 articles
Broad modality coverage (8 modalities)
Recent News 6 articles
Drug-Manufacturing Localization Strategy in China - BioProcess International
Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License - PR Newswire
Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development - PR Newswire
Innovent’s CDMO gets green light to make biologics at large Chinese plant - BioSpace
Altruist Biologics’ Hangzhou Facility Gets First Commercial-Scale Manufacturing License - Contract Pharma
Altruist Biologics expands in China amid growing biologics market - BioProcess International
Frequently Asked Questions About Altruist Biologics
What is Altruist Biologics's CDMO Signal Score?
Altruist Biologics has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Altruist Biologics for a manufacturing program?
Use the free AI matchmaker to compare Altruist Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Abzena
San Diego, CA; Bristol, PA; Cambridge, UK
Signal Score: 64.0
ADC, AOC, RDC, PDC, DAC, Fusion Proteins, Bispecifics, bsAbs, Multispecifics, msAbs, Bioconjugates, Biologics, mAb, Monoclonal Antibody, Antibodies, Cytokines, HPAPI, Bioconjugation
Roche / Genentech (Internal Manufacturing & CustomBiotech)
Basel, Switzerland
Biologics, mAb, Cell Therapy, Gene Therapy (AAV), Oligonucleotide, mRNA, Small Molecule
Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma)
Lianyungang, China
Small Molecule API, Biologics, Monoclonal Antibody, ADC, Oncology Drugs, Surgical Medicines
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 83.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody